Avid Bioservices Inc

NASDAQ:CDMO  
15.61
-0.12 (-0.76%)
Products, Expansion

Avid Bioservices Announces Further Expansion Of Process Development Capacity For Mammalian Cell Business

Published: 06/13/2022 12:34 GMT
Avid Bioservices Inc (CDMO) - Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business.
Avid Bioservices Inc - Expansion to Cost Approximately $6 Million With Completion Anticipated by End of Calendar 2022.